id	sid	tid	token	lemma	pos
work_cmb5a3ntvzalhowblcxqo6o7xy	1	1	Vogelmeier	Vogelmeier	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	2	Respiratory	Respiratory	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	3	Research	Research	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	4	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	1	5	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	1	6	15:38	15:38	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	1	7	http://respiratory-research.com/content/15/1/38	http://respiratory-research.com/content/15/1/38	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	8	COMMENTARY	commentary	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	9	Open	open	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	1	10	Access	Access	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	11	Systemic	Systemic	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	12	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	1	13	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	14	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	15	-	-	:
work_cmb5a3ntvzalhowblcxqo6o7xy	1	16	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	1	17	beauty	beauty	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	18	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	1	19	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	1	20	beast	beast	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	21	Claus	Claus	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	22	F	F	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	23	Vogelmeier1,2	Vogelmeier1,2	NFP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	24	The	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	1	25	recommendations	recommendation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	1	26	regarding	regard	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	1	27	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	1	28	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	29	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	30	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	1	31	ste-	ste-	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	1	32	roids	roid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	1	33	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	34	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	35	differ	differ	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	1	36	substantially	substantially	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	1	37	depending	depend	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	1	38	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	39	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	1	40	phase	phase	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	41	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	42	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	1	43	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	1	44	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	2	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	2	moderate	moderate	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	3	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	2	4	severe	severe	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	5	acute	acute	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	6	exac-	exac-	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	2	7	erbations	erbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	8	oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	9	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	10	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	2	11	advocated	advocate	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	12	based	base	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	13	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	14	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	2	15	find-	find-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	16	ings	ing	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	17	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	18	several	several	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	19	placebo	placebo	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	20	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	2	21	controlled	control	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	22	trials	trial	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	23	that	that	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	2	24	have	have	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	2	25	been	be	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	26	performed	perform	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	27	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	28	secondary	secondary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	29	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	2	30	care	care	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	31	settings	setting	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	32	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	2	33	these	these	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	2	34	studies	study	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	35	showed	show	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	2	36	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	37	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	2	38	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	2	39	improve	improve	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	2	40	lung	lung	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	41	function	function	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	42	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	2	43	dyspnoea	dyspnoea	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	44	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	2	45	gas	gas	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	46	exchange	exchange	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	2	47	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	3	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	2	addition	addition	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	3	4	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	5	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	6	re-	re-	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	3	7	sulted	sulte	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	3	8	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	9	fewer	few	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	3	10	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	11	failures	failure	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	3	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	3	13	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	3	14	lower	low	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	3	15	relapse	relapse	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	16	rate	rate	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	17	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	3	18	shorter	short	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	3	19	hospital	hospital	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	3	20	stays	stay	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	3	21	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	3	22	1	1	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	3	23	-	-	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	3	24	4	4	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	3	25	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	3	26	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	4	1	Importantly	importantly	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	4	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	4	3	giving	give	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	4	4	ste-	ste-	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	4	5	roids	roid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	4	6	orally	orally	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	4	7	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	4	8	non	non	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	4	9	-	-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	4	10	inferior	inferior	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	4	11	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	4	12	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	4	13	i.v	i.v	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	4	14	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	5	1	application	application	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	5	2	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	5	3	5	5	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	5	4	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	5	5	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	5	6	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	5	7	8-week	8-week	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	5	8	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	5	9	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	5	10	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	5	11	superior	superior	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	5	12	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	5	13	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	5	14	2-week	2-week	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	5	15	therapy	therapy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	5	16	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	5	17	6	6	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	5	18	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	5	19	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	6	1	Recently	recently	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	6	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	6	3	it	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	6	4	could	could	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	6	5	even	even	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	6	6	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	6	7	shown	show	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	6	8	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	6	9	5-day	5-day	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	6	10	treat-	treat-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	6	11	ment	ment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	6	12	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	6	13	non	non	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	6	14	-	-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	6	15	inferior	inferior	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	6	16	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	6	17	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	6	18	14-day	14-day	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	6	19	course	course	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	6	20	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	6	21	7	7	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	6	22	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	6	23	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	7	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	2	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	7	3	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	4	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	5	longer	long	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	7	6	term	term	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	7	therapy	therapy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	8	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	7	9	6	6	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	7	10	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	7	11	hyperglycemia	hyperglycemia	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	12	requiring	require	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	7	13	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	14	was	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	7	15	identified	identify	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	16	as	as	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	17	considerable	considerable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	7	18	side	side	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	19	effect	effect	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	20	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	7	21	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	22	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	7	23	other	other	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	7	24	trials	trial	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	7	25	no	no	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	7	26	major	major	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	7	27	adverse	adverse	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	7	28	events	event	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	7	29	were	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	7	30	observed	observe	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	7	31	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	8	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	2	contrast	contrast	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	8	4	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	5	stable	stable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	8	6	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	8	7	positive	positive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	8	8	effects	effect	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	8	9	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	10	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	8	11	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	8	12	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	8	13	scarce	scarce	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	8	14	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	8	15	there	there	EX
work_cmb5a3ntvzalhowblcxqo6o7xy	8	16	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	8	17	some	some	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	8	18	evidence	evidence	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	19	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	20	higher	high	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	8	21	doses	dose	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	8	22	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	8	23	≥	≥	UH
work_cmb5a3ntvzalhowblcxqo6o7xy	8	24	30	30	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	8	25	mg	mg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	8	26	prednisolone	prednisolone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	27	/	/	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	8	28	day	day	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	29	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	8	30	may	may	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	8	31	improve	improve	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	8	32	lung	lung	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	33	function	function	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	34	over	over	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	35	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	8	36	short	short	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	8	37	period	period	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	38	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	8	39	whereas	whereas	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	40	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	8	41	was	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	8	42	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	8	43	ob-	ob-	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	8	44	served	serve	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	45	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	46	doses	dose	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	8	47	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	48	less	less	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	8	49	than	than	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	50	10–15	10–15	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	8	51	mg	mg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	8	52	prednisolone	prednisolone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	53	/	/	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	8	54	day	day	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	8	55	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	8	56	8	8	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	8	57	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	8	58	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	9	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	2	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	9	3	2-year	2-year	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	9	4	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	5	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	6	5	5	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	9	7	mg	mg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	9	8	prednisolone	prednisolone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	9	+	+	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	9	10	1600	1600	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	9	11	μg	μg	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	12	budesonide	budesonide	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	13	/	/	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	9	14	day	day	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	15	efficacy	efficacy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	16	regarding	regard	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	9	17	lung	lung	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	18	function	function	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	19	decline	decline	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	20	was	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	9	21	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	9	22	significantly	significantly	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	9	23	better	well	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	9	24	than	than	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	9	25	budesonide	budesonide	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	9	26	alone	alone	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	9	27	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	9	28	9	9	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	9	29	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	9	30	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	10	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	10	2	addition	addition	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	10	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	10	4	there	there	EX
work_cmb5a3ntvzalhowblcxqo6o7xy	10	5	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	10	6	substantial	substantial	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	10	7	side	side	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	10	8	effect	effect	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	10	9	problems	problem	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	10	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	11	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	11	2	particular	particular	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	11	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	11	4	it	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	11	5	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	11	6	well	well	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	11	7	established	establish	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	11	8	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	11	9	respiratory	respiratory	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	11	10	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	11	11	per-	per-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	11	12	ipheral	ipheral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	11	13	muscle	muscle	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	11	14	strength	strength	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	11	15	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	11	16	10	10	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	11	17	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	11	18	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	11	19	affected	affect	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	11	20	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	12	1	This	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	12	2	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	12	3	caused	cause	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	4	by	by	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	5	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	12	6	myopathy	myopathy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	7	that	that	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	12	8	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	12	9	characterized	characterize	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	10	by	by	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	11	atrophy	atrophy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	12	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	12	13	ne-	ne-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	12	14	crosis	crosis	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	15	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	12	16	11	11	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	12	17	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	12	18	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	12	19	may	may	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	12	20	lead	lead	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	12	21	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	22	reduced	reduced	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	12	23	survival	survival	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	12	24	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	13	1	Besides	besides	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	13	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	13	3	there	there	EX
work_cmb5a3ntvzalhowblcxqo6o7xy	13	4	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	5	evidence	evidence	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	6	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	7	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	8	therapy	therapy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	9	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	10	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	11	ste-	ste-	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	13	12	roids	roid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	13	13	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	14	one	one	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	13	15	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	16	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	13	17	risk	risk	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	18	factors	factor	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	13	19	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	20	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	13	21	high	high	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	22	rate	rate	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	23	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	24	osteo-	osteo-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	25	porosis	porosis	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	26	that	that	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	13	27	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	13	28	observed	observe	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	29	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	13	30	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	13	31	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	13	32	12	12	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	13	33	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	13	34	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	14	1	What	what	WP
work_cmb5a3ntvzalhowblcxqo6o7xy	14	2	does	do	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	14	3	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	14	4	paper	paper	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	14	5	by	by	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	14	6	Horita	Horita	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	14	7	et	et	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	14	8	al	al	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	14	9	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	15	1	published	publish	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	2	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	3	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	15	4	issue	issue	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	5	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	6	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	15	7	journal	journal	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	8	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	15	9	13	13	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	15	10	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	15	11	add	add	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	15	12	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	13	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	15	14	literature	literature	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	15	15	?	?	.
work_cmb5a3ntvzalhowblcxqo6o7xy	16	1	To	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	2	my	-PRON-	PRP$
work_cmb5a3ntvzalhowblcxqo6o7xy	16	3	knowledge	knowledge	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	4	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	5	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	16	6	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	7	first	first	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	16	8	analysis	analysis	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	9	that	that	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	10	systematically	systematically	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	16	11	evaluates	evaluate	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	16	12	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	13	effects	effect	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	16	14	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	15	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	16	16	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	16	17	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	18	mortality	mortality	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	19	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	20	Correspondence	Correspondence	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	21	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	16	22	Claus.Vogelmeier@med.uni-marburg.de	Claus.Vogelmeier@med.uni-marburg.de	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	23	1Department	1department	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	16	24	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	25	Medicine	Medicine	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	26	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	27	Pulmonary	Pulmonary	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	28	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	16	29	Critical	Critical	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	30	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	31	Medicine	Medicine	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	32	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	33	35033	35033	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	16	34	Marburg	Marburg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	35	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	36	Germany	Germany	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	37	2Member	2Member	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	38	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	39	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	40	German	German	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	41	Center	Center	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	42	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	43	Lung	Lung	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	44	Research	Research	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	45	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	16	46	DZL	DZL	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	47	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	16	48	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	49	University	University	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	50	Medical	Medical	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	51	Center	Center	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	52	Giessen	Giessen	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	53	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	16	54	Marburg	Marburg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	55	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	56	Philipps	Philipps	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	57	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	16	58	Universität	Universität	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	59	Marburg	Marburg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	60	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	61	35033	35033	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	16	62	Marburg	Marburg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	63	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	64	Germany	Germany	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	65	©	©	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	66	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	16	67	Vogelmeier	vogelmeier	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	68	;	;	:
work_cmb5a3ntvzalhowblcxqo6o7xy	16	69	licensee	licensee	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	70	BioMed	BioMed	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	71	Central	Central	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	72	L	L	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	73	Commons	Commons	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	74	Attribution	Attribution	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	75	License	License	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	76	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	16	77	http://creativec	http://creativec	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	78	reproduction	reproduction	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	79	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	80	any	any	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	81	medium	medium	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	82	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	16	83	provided	provide	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	16	84	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	16	85	or	or	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	16	86	Dedication	Dedication	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	16	87	waiver	waiver	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	88	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	16	89	http://creativecommons.or	http://creativecommons.or	FW
work_cmb5a3ntvzalhowblcxqo6o7xy	16	90	unless	unless	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	91	otherwise	otherwise	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	16	92	stated	state	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	16	93	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	17	1	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	17	2	considerable	considerable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	17	3	sample	sample	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	17	4	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	17	5	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	17	6	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	17	7	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	17	8	severe	severe	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	17	9	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	17	10	very	very	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	17	11	severe	severe	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	17	12	COPD	COPD	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	17	13	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	18	1	The	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	18	2	authors	author	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	18	3	analyzed	analyze	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	18	4	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	18	5	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	18	6	N	n	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	7	=	=	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	18	8	444	444	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	18	9	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	18	10	that	that	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	18	11	had	have	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	18	12	been	be	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	13	randomized	randomize	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	14	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	15	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	18	16	conservative	conservative	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	18	17	treat-	treat-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	18	18	ment	ment	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	18	19	arm	arm	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	20	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	21	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	18	22	National	National	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	18	23	Emphysema	Emphysema	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	18	24	Treatment	Treatment	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	18	25	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	18	26	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	18	27	NETT	NETT	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	18	28	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	18	29	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	19	1	They	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	19	2	calculated	calculate	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	19	3	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	19	4	hazard	hazard	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	5	ratio	ratio	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	6	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	7	death	death	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	8	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	9	1.54	1.54	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	19	10	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	11	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	19	12	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	13	user	user	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	14	group	group	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	19	15	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	20	1	Then	then	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	20	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	20	3	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	4	order	order	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	5	to	to	TO
work_cmb5a3ntvzalhowblcxqo6o7xy	20	6	make	make	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	20	7	sure	sure	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	20	8	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	9	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	20	10	result	result	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	11	was	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	20	12	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	20	13	induced	induce	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	14	by	by	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	15	unidentified	unidentified	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	20	16	con-	con-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	17	founders	founder	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	20	18	they	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	20	19	performed	perform	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	20	20	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	20	21	propensity	propensity	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	22	score	score	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	20	23	matching	match	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	20	24	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	21	1	Based	base	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	2	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	3	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	21	4	analysis	analysis	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	5	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	21	6	hazard	hazard	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	7	ratio	ratio	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	8	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	9	death	death	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	10	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	11	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	21	12	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	13	group	group	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	21	14	was	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	21	15	1.73	1.73	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	21	16	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	22	1	Thus	thus	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	22	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	22	3	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	22	4	observed	observed	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	22	5	effect	effect	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	22	6	seems	seem	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	22	7	to	to	TO
work_cmb5a3ntvzalhowblcxqo6o7xy	22	8	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	22	9	robust	robust	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	22	10	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	22	11	real	real	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	22	12	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	23	1	Nevertheless	nevertheless	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	23	3	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	4	authors	author	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	5	righteously	righteously	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	6	mention	mention	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	7	several	several	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	8	potential	potential	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	9	weaknesses	weakness	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	10	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	11	their	-PRON-	PRP$
work_cmb5a3ntvzalhowblcxqo6o7xy	23	12	study	study	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	13	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	23	14	a	a	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	15	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	23	16	it	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	17	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	18	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	19	prospect-	prospect-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	20	i	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	21	ve	have	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	22	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	23	23	but	but	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	23	24	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	25	prospective	prospective	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	26	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	27	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	28	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	29	endpoint	endpoint	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	30	does	do	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	31	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	32	seem	seem	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	33	feasible	feasible	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	34	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	23	35	b	b	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	36	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	23	37	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	38	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	39	dose	dose	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	40	was	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	23	41	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	42	verified	verify	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	43	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	23	44	c	c	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	45	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	23	46	only	only	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	47	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	48	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	49	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	50	FEV1	FEV1	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	51	≤	≤	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	52	45	45	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	23	53	%	%	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	54	predicted	predict	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	23	55	had	have	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	23	56	been	be	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	57	in-	in-	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	58	cluded	clude	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	59	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	60	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	61	NETT	NETT	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	62	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	63	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	23	64	but	but	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	23	65	logic	logic	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	66	tells	tell	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	67	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	68	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	69	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	70	should	should	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	23	71	only	only	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	72	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	73	considered	consider	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	74	when	when	WRB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	75	all	all	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	76	other	other	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	77	ther-	ther-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	78	apies	apie	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	79	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	80	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	81	sufficiently	sufficiently	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	82	effective	effective	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	83	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	23	84	it	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	23	85	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	86	quite	quite	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	23	87	unlikely	unlikely	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	88	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	89	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	90	occurs	occur	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	91	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	92	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	23	93	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	94	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	23	95	moderate	moderate	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	23	96	lung	lung	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	97	func-	func-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	98	tion	tion	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	99	impairment	impairment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	23	100	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	24	1	It	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	24	2	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	24	3	quite	quite	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	24	4	worrisome	worrisome	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	24	5	though	though	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	6	that	that	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	24	7	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	8	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	24	9	NETT	NETT	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	24	10	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	11	only	only	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	24	12	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	24	13	minority	minority	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	14	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	15	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	24	16	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	24	17	were	be	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	24	18	treated	treat	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	19	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	20	long	long	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	24	21	acting	acting	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	24	22	bronchodilators	bronchodilator	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	24	23	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	25	1	In	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	2	summary	summary	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	25	4	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	25	5	study	study	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	6	results	result	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	25	7	support	support	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	25	8	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	25	9	recommen-	recommen-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	10	dations	dation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	25	11	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	12	guidelines	guideline	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	25	13	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	25	14	strategy	strategy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	15	documents	document	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	25	16	to	to	TO
work_cmb5a3ntvzalhowblcxqo6o7xy	25	17	stay	stay	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	25	18	away	away	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	25	19	from	from	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	20	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	25	21	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	25	22	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	23	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	24	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	25	25	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	25	26	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	25	27	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	25	28	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	25	29	14	14	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	25	30	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	25	31	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	26	1	As	as	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	2	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	26	3	consequence	consequence	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	4	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	26	5	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	6	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	26	7	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	8	stable	stable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	26	9	condition	condition	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	10	that	that	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	26	11	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	26	12	currently	currently	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	26	13	treated	treat	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	14	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	15	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	26	16	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	26	17	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	26	18	therapy	therapy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	19	should	should	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	26	20	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	26	21	tapered	taper	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	22	/	/	,
work_cmb5a3ntvzalhowblcxqo6o7xy	26	23	stopped	stop	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	26	24	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	27	1	This	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	27	2	can	can	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	27	3	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	27	4	quite	quite	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	27	5	demanding	demanding	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	27	6	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	27	7	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	27	8	may	may	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	27	9	develop	develop	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	27	10	fatigue	fatigue	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	27	11	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	27	12	low	low	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	27	13	blood	blood	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	27	14	pressure	pressure	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	27	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	27	16	joint	joint	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	27	17	pain	pain	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	27	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	27	19	weakness	weakness	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	27	20	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	27	21	even	even	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	27	22	psychotic	psychotic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	27	23	symp-	symp-	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	27	24	toms	toms	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	27	25	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	27	26	15	15	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	27	27	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	27	28	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	28	1	Importantly	importantly	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	28	2	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	28	3	discontinuation	discontinuation	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	4	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	5	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	28	6	sys-	sys-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	7	temic	temic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	28	8	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	9	therapy	therapy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	10	did	do	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	28	11	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	28	12	result	result	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	28	13	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	14	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	28	15	increase	increase	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	16	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	17	COPD	copd	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	28	18	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	28	19	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	28	20	16	16	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	28	21	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	28	22	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	29	1	There	there	EX
work_cmb5a3ntvzalhowblcxqo6o7xy	29	2	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	29	3	only	only	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	29	4	one	one	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	29	5	scenario	scenario	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	6	where	where	WRB
work_cmb5a3ntvzalhowblcxqo6o7xy	29	7	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	8	cessation	cessation	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	9	may	may	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	29	10	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	29	11	harmful	harmful	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	29	12	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	29	13	some	some	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	29	14	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	29	15	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	16	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	29	17	asthma	asthma	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	18	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	29	19	COPD	COPD	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	29	20	overlap	overlap	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	21	may	may	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	29	22	profit	profit	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	29	23	from	from	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	24	long-	long-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	29	25	term	term	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	26	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	27	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	28	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	29	29	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	29	30	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	29	31	17	17	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	29	32	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	29	33	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	29	34	may	may	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	29	35	get	get	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	29	36	worse	bad	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	29	37	when	when	WRB
work_cmb5a3ntvzalhowblcxqo6o7xy	29	38	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	29	39	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	29	40	stopped	stop	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	29	41	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	30	1	Based	base	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	2	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	3	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	30	4	cited	cite	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	5	literature	literature	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	6	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	30	7	supported	support	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	8	by	by	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	9	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	30	10	findings	finding	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	30	11	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	30	12	Horita	Horita	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	30	13	et	et	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	30	14	al	al	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	30	15	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	31	1	[	[	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	31	2	13	13	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	31	3	]	]	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	31	4	there	there	EX
work_cmb5a3ntvzalhowblcxqo6o7xy	31	5	are	be	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	31	6	some	some	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	31	7	simple	simple	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	31	8	mes-	mes-	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	9	sages	sage	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	10	regarding	regard	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	31	11	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	31	12	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	31	13	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	31	14	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	31	15	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	16	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	31	17	COPD	COPD	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	18	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	31	19	a	a	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	20	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	31	21	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	31	22	moderate	moderate	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	31	23	or	or	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	31	24	severe	severe	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	31	25	acute	acute	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	31	26	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	27	oral	oral	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	31	28	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	31	29	td	td	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	31	30	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	32	1	This	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	32	2	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	32	3	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	32	4	Open	open	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	32	5	Access	access	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	6	article	article	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	7	distributed	distribute	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	8	under	under	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	9	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	32	10	terms	term	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	32	11	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	12	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	32	13	Creative	Creative	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	32	14	ommons.org/licenses/by/4.0	ommons.org/licenses/by/4.0	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	15	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	32	16	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	32	17	which	which	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	32	18	permits	permit	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	32	19	unrestricted	unrestricted	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	32	20	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	32	22	distribution	distribution	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	23	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	32	24	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	32	25	iginal	iginal	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	32	26	work	work	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	27	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	32	28	properly	properly	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	32	29	credited	credit	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	32	30	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	33	1	The	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	2	Creative	Creative	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	3	Commons	Commons	NNPS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	4	Public	Public	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	5	Domain	Domain	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	6	g	g	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	7	/	/	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	33	8	publicdomain	publicdomain	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	9	/	/	SYM
work_cmb5a3ntvzalhowblcxqo6o7xy	33	10	zero/1.0/	zero/1.0/	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	11	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	33	12	applies	apply	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	13	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	14	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	15	data	datum	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	16	made	make	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	17	available	available	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	18	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	19	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	20	article	article	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	33	22	mailto:Claus.Vogelmeier@med.uni-marburg.de	mailto:Claus.Vogelmeier@med.uni-marburg.de	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	23	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	24	http://creativecommons.org/publicdomain/zero/1.0/	http://creativecommons.org/publicdomain/zero/1.0/	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	25	Vogelmeier	Vogelmeier	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	26	Respiratory	Respiratory	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	27	Research	Research	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	28	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	29	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	33	30	15:38	15:38	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	31	Page	page	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	32	2	2	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	33	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	34	2	2	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	35	http://respiratory-research.com/content/15/1/38	http://respiratory-research.com/content/15/1/38	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	36	should	should	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	37	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	38	prescribed	prescribe	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	39	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	40	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	41	moderate	moderate	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	42	dose	dose	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	43	(	(	-LRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	33	44	40	40	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	45	mg	mg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	46	pred-	pred-	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	47	nisolone	nisolone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	48	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	33	49	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	50	5	5	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	51	days	day	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	52	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	33	53	b	b	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	54	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	33	55	there	there	EX
work_cmb5a3ntvzalhowblcxqo6o7xy	33	56	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	57	no	no	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	58	place	place	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	59	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	60	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	61	ste-	ste-	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	62	roids	roid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	63	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	64	stable	stable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	65	phase	phase	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	66	COPD	COPD	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	67	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	33	68	c	c	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	69	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	33	70	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	71	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	72	treated	treat	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	73	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	74	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	75	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	76	outside	outside	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	77	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	78	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	79	exacerbation	exacerbation	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	80	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	81	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	82	should	should	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	83	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	84	withdrawn	withdraw	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	85	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	33	86	d	d	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	87	)	)	-RRB-
work_cmb5a3ntvzalhowblcxqo6o7xy	33	88	before	before	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	89	doing	do	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	33	90	so	so	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	91	ther-	ther-	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	92	apy	apy	UH
work_cmb5a3ntvzalhowblcxqo6o7xy	33	93	should	should	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	94	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	95	optimized	optimize	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	96	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	33	97	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	33	98	should	should	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	33	99	be	be	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	100	re-	re-	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	101	evaluated	evaluate	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	102	to	to	TO
work_cmb5a3ntvzalhowblcxqo6o7xy	33	103	make	make	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	104	sure	sure	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	105	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	106	they	-PRON-	PRP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	107	do	do	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	108	not	not	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	109	have	have	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	33	110	an	an	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	33	111	asthma-	asthma-	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	33	112	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	33	113	overlap	overlap	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	33	114	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	34	1	Received	receive	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	34	2	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	34	3	10	10	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	4	March	March	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	34	5	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	6	Accepted	accept	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	34	7	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	34	8	25	25	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	9	March	March	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	34	10	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	11	Published	publish	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	34	12	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	34	13	3	3	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	14	April	April	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	34	15	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	16	References	reference	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	34	17	1	1	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	34	18	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	35	1	Thompson	Thompson	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	2	WH	WH	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	35	4	Nielson	Nielson	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	5	CP	CP	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	35	7	Carvalho	Carvalho	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	8	P	P	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	35	10	Charan	Charan	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	11	NB	NB	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	35	13	Crowley	Crowley	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	14	JJ	JJ	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	15	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	35	16	Controlled	control	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	17	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	18	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	19	oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	35	20	prednisone	prednisone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	21	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	22	outpatients	outpatient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	35	23	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	24	acute	acute	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	35	25	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	35	26	exacerbation	exacerbation	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	35	27	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	36	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	36	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	36	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	36	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	36	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	36	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	36	7	1996	1996	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	36	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	36	9	154:407–412	154:407–412	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	36	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	37	1	2	2	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	37	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	38	1	Davies	davy	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	38	2	L	L	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	38	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	38	4	Angus	Angus	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	38	5	RM	RM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	38	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	38	7	Calverley	Calverley	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	38	8	PM	pm	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	9	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	38	10	Oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	38	11	corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	38	12	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	13	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	38	14	admitted	admit	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	38	15	to	to	TO
work_cmb5a3ntvzalhowblcxqo6o7xy	38	16	hospital	hospital	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	17	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	18	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	38	19	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	20	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	38	21	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	38	22	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	38	23	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	24	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	38	25	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	38	26	prospective	prospective	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	38	27	randomised	randomise	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	28	controlled	controlled	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	38	29	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	38	30	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	39	1	Lancet	Lancet	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	39	2	1999	1999	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	39	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	39	4	354:456–460	354:456–460	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	39	5	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	40	1	3	3	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	40	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	41	1	Maltais	Maltais	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	2	F	F	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	4	Ostinelli	Ostinelli	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	5	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	7	Bourbeau	Bourbeau	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	8	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	10	Tonnel	Tonnel	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	11	AB	AB	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	13	Jacquemet	Jacquemet	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	14	N	N	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	16	Haddon	Haddon	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	17	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	19	Rouleau	Rouleau	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	20	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	22	Boukhana	Boukhana	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	23	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	24	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	25	Martinot	Martinot	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	26	JB	JB	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	27	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	41	28	Duroux	Duroux	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	29	P	P	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	41	30	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	41	31	Comparison	comparison	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	32	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	33	nebulized	nebulize	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	34	budesonide	budesonide	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	35	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	41	36	oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	37	prednisolone	prednisolone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	38	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	39	placebo	placebo	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	40	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	41	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	41	42	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	43	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	44	acute	acute	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	45	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	41	46	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	47	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	48	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	49	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	50	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	51	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	41	52	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	41	53	randomized	randomized	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	54	controlled	controlled	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	41	55	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	41	56	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	42	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	42	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	42	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	42	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	42	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	42	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	42	7	2002	2002	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	42	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	42	9	165:698–703	165:698–703	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	42	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	43	1	4	4	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	43	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	44	1	Aaron	Aaron	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	2	SD	SD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	4	Vandemheen	Vandemheen	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	5	KL	KL	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	7	Hebert	Hebert	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	8	P	P	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	10	Dales	Dales	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	11	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	13	Stiell	Stiell	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	14	IG	IG	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	16	Ahuja	Ahuja	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	17	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	19	Dickinson	Dickinson	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	20	G	G	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	22	Brison	Brison	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	23	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	24	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	25	Rowe	Rowe	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	26	BH	BH	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	27	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	28	Dreyer	Dreyer	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	29	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	30	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	31	Yetisir	Yetisir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	32	E	E	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	33	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	34	Cass	Cass	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	35	D	D	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	36	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	44	37	Wells	Wells	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	38	G	G	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	44	39	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	44	40	Outpatient	outpatient	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	41	oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	44	42	prednisone	prednisone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	43	after	after	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	44	emergency	emergency	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	45	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	46	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	47	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	44	48	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	44	49	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	44	50	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	44	51	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	45	1	N	N	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	45	2	Engl	Engl	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	45	3	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	45	4	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	45	5	2003	2003	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	45	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	45	7	348:2618–2625	348:2618–2625	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	45	8	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	46	1	5	5	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	46	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	46	3	de	de	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	4	Jong	Jong	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	5	YP	YP	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	7	Uil	Uil	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	8	SM	SM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	10	Grotjohan	Grotjohan	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	11	HP	HP	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	13	Postma	Postma	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	14	DS	DS	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	16	Kerstjens	Kerstjens	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	17	HA	HA	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	19	van	van	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	20	den	den	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	21	Berg	Berg	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	22	JW	JW	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	23	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	46	24	Oral	Oral	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	25	or	or	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	46	26	IV	IV	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	27	prednisolone	prednisolone	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	28	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	29	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	46	30	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	31	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	32	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	46	33	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	46	34	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	46	35	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	46	36	randomized	randomized	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	46	37	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	38	controlled	control	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	39	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	46	40	double	double	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	46	41	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	46	42	blind	blind	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	46	43	study	study	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	46	44	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	47	1	Chest	Chest	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	47	2	2007	2007	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	47	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	47	4	132:1741–1747	132:1741–1747	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	47	5	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	48	1	6	6	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	48	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	49	1	Niewoehner	Niewoehner	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	2	DE	DE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	4	Erbland	Erbland	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	5	ML	ML	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	7	Deupree	Deupree	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	8	RH	RH	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	10	Collins	Collins	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	11	D	D	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	13	Gross	Gross	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	14	NJ	NJ	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	16	Light	Light	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	17	RW	RW	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	19	Anderson	Anderson	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	20	P	P	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	49	22	Morgan	Morgan	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	23	NA	NA	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	49	24	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	49	25	Effect	effect	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	49	26	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	49	27	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	49	28	glucocorticoids	glucocorticoid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	49	29	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	49	30	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	49	31	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	49	32	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	49	33	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	49	34	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	49	35	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	49	36	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	50	1	Department	department	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	50	2	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	50	3	veterans	veteran	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	50	4	affairs	affair	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	50	5	cooperative	cooperative	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	50	6	study	study	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	50	7	group	group	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	50	8	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	51	1	N	N	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	51	2	Engl	Engl	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	51	3	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	51	4	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	51	5	1999	1999	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	51	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	51	7	340:1941–1947	340:1941–1947	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	51	8	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	52	1	7	7	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	52	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	53	1	Leuppi	Leuppi	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	2	JD	JD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	4	Schuetz	Schuetz	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	5	P	P	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	7	Bingisser	Bingisser	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	8	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	10	Bodmer	Bodmer	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	11	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	13	Briel	Briel	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	14	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	16	Drescher	Drescher	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	17	T	T	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	19	Duerring	Duerring	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	20	U	U	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	22	Henzen	Henzen	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	23	C	C	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	24	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	25	Leibbrandt	Leibbrandt	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	26	Y	Y	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	27	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	28	Maier	Maier	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	29	S	S	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	30	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	31	Miedinger	Miedinger	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	32	D	D	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	33	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	34	Müller	Müller	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	35	B	B	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	36	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	37	Scherr	Scherr	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	38	A	A	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	39	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	40	Schindler	Schindler	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	41	C	C	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	42	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	43	Stoeckli	Stoeckli	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	44	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	45	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	46	Viatte	Viatte	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	47	S	S	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	48	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	49	von	von	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	50	Garnier	Garnier	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	51	C	C	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	52	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	53	Tamm	Tamm	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	54	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	55	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	53	56	Rutishauser	Rutishauser	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	57	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	58	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	53	59	Short	short	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	60	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	53	61	term	term	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	62	vs	vs	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	63	conventional	conventional	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	64	glucocorticoid	glucocorticoid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	65	therapy	therapy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	66	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	67	acute	acute	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	68	exacerbations	exacerbation	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	53	69	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	70	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	71	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	72	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	73	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	74	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	53	75	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	53	76	REDUCE	REDUCE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	53	77	randomized	randomize	VBD
work_cmb5a3ntvzalhowblcxqo6o7xy	53	78	clinical	clinical	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	53	79	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	53	80	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	54	1	JAMA	JAMA	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	54	2	2013	2013	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	54	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	54	4	309:2223–22331	309:2223–22331	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	54	5	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	55	1	8	8	LS
work_cmb5a3ntvzalhowblcxqo6o7xy	55	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	56	1	Walters	Walters	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	2	JA	JA	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	56	4	Walters	Walters	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	5	EH	EH	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	56	7	Wood	Wood	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	8	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	56	9	Baker	Baker	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	10	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	56	11	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	56	12	Oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	56	13	corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	56	14	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	56	15	stable	stable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	56	16	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	56	17	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	56	18	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	56	19	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	56	20	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	57	1	Cochrane	Cochrane	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	57	2	Database	Database	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	57	3	Syst	Syst	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	57	4	Rev	Rev	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	57	5	2005	2005	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	57	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	57	7	3	3	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	57	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	57	9	CD005374	CD005374	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	57	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	58	1	9	9	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	58	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	59	1	Renkema	Renkema	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	2	TE	TE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	59	4	Schouten	Schouten	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	5	JP	JP	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	59	7	Koëter	Koëter	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	8	GH	GH	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	59	10	Postma	Postma	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	11	DS	DS	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	12	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	59	13	Effects	effect	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	59	14	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	59	15	long	long	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	59	16	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	59	17	term	term	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	59	18	treatment	treatment	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	59	19	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	59	20	corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	59	21	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	59	22	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	59	23	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	60	1	Chest	chest	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	60	2	1996	1996	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	60	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	60	4	109:1156–1162	109:1156–1162	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	60	5	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	61	1	10	10	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	61	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	62	1	Decramer	Decramer	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	2	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	62	4	Lacquet	Lacquet	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	5	LM	LM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	62	7	Fagard	Fagard	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	8	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	62	10	Rogiers	Rogiers	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	11	P	p	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	12	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	62	13	Corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	62	14	contribute	contribute	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	62	15	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	16	muscle	muscle	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	17	weakness	weakness	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	18	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	19	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	62	20	airflow	airflow	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	21	obstruction	obstruction	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	62	22	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	63	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	63	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	63	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	63	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	63	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	63	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	63	7	1994	1994	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	63	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	63	9	150:11–16	150:11–16	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	63	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	64	1	11	11	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	64	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	65	1	Decramer	Decramer	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	2	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	65	4	de	de	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	5	Bock	Bock	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	6	V	V	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	7	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	65	8	Dom	Dom	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	9	R	r	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	10	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	65	11	Functional	functional	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	65	12	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	65	13	histologic	histologic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	65	14	picture	picture	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	15	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	16	steroid	steroid	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	17	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	65	18	induced	induce	VBN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	19	myopathy	myopathy	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	65	20	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	21	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	65	22	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	65	23	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	65	24	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	65	25	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	66	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	66	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	66	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	66	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	66	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	66	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	66	7	1996	1996	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	66	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	66	9	153:1958–1964	153:1958–1964	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	66	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	67	1	12	12	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	67	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	68	1	McEvoy	McEvoy	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	2	CE	CE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	68	4	Ensrud	Ensrud	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	5	KE	KE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	68	7	Bender	Bender	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	8	E	E	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	68	10	Genant	Genant	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	11	HK	HK	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	68	13	Yu	Yu	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	14	W	W	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	68	16	Griffith	Griffith	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	17	JM	JM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	68	19	Niewoehner	Niewoehner	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	20	DE	DE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	21	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	68	22	Association	Association	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	23	between	between	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	68	24	corticosteroid	corticosteroid	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	68	25	use	use	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	68	26	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	68	27	vertebral	vertebral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	68	28	fractures	fracture	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	68	29	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	68	30	older	old	JJR
work_cmb5a3ntvzalhowblcxqo6o7xy	68	31	men	man	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	68	32	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	68	33	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	68	34	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	68	35	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	68	36	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	68	37	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	69	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	69	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	69	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	69	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	69	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	69	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	69	7	1998	1998	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	69	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	69	9	157:704–709	157:704–709	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	69	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	70	1	13	13	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	70	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	71	1	Horita	Horita	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	2	N	N	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	71	4	Miyazawa	Miyazawa	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	5	N	N	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	71	7	Morita	Morita	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	8	S	S	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	71	10	Kojima	Kojima	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	11	R	R	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	71	13	Inoue	Inoue	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	14	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	71	16	Ishigatsubo	Ishigatsubo	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	17	Y	Y	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	71	19	Kaneko	Kaneko	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	20	T	T	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	21	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	71	22	Evidence	evidence	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	71	23	suggesting	suggest	VBG
work_cmb5a3ntvzalhowblcxqo6o7xy	71	24	that	that	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	71	25	oral	oral	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	71	26	corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	71	27	increase	increase	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	71	28	mortality	mortality	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	71	29	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	71	30	stable	stable	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	71	31	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	71	32	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	71	33	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	71	34	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	71	35	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	72	1	Resp	Resp	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	72	2	Res	Res	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	72	3	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	72	4	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	72	5	15:37	15:37	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	72	6	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	73	1	14	14	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	73	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	74	1	Vestbo	Vestbo	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	4	Hurd	Hurd	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	5	SS	SS	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	7	Agustí	Agustí	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	8	AG	AG	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	10	Jones	Jones	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	11	PW	PW	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	13	Vogelmeier	Vogelmeier	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	14	C	C	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	16	Anzueto	Anzueto	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	17	A	A	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	19	Barnes	Barnes	NNPS
work_cmb5a3ntvzalhowblcxqo6o7xy	74	20	PJ	PJ	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	22	Fabbri	Fabbri	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	23	LM	LM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	24	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	25	Martinez	Martinez	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	26	FJ	FJ	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	27	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	28	Nishimura	Nishimura	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	29	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	30	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	31	Stockley	Stockley	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	32	RA	RA	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	33	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	34	Sin	Sin	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	35	DD	DD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	36	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	37	Rodriguez	Rodriguez	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	38	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	74	39	Roisin	Roisin	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	74	40	R	r	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	41	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	74	42	Global	global	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	74	43	strategy	strategy	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	44	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	45	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	74	46	diagnosis	diagnosis	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	47	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	48	management	management	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	49	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	74	50	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	74	51	prevention	prevention	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	52	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	53	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	74	54	obstructive	obstructive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	74	55	pulmonary	pulmonary	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	74	56	disease	disease	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	57	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	74	58	GOLD	gold	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	74	59	executive	executive	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	74	60	summary	summary	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	74	61	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	75	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	75	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	75	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	75	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	75	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	75	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	75	7	2013	2013	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	75	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	75	9	187:347–365	187:347–365	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	75	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	76	1	15	15	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	76	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	77	1	Mercadante	Mercadante	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	77	2	S	S	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	77	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	77	4	Villari	Villari	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	77	5	P	P	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	77	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	77	7	Intravaia	Intravaia	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	77	8	G	G	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	77	9	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	77	10	Withdrawal	withdrawal	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	77	11	acute	acute	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	77	12	psychosis	psychosis	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	77	13	after	after	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	77	14	corticosteroid	corticosteroid	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	77	15	discontinuation	discontinuation	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	77	16	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	78	1	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	78	2	Pain	Pain	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	78	3	Symptom	symptom	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	78	4	Manage	Manage	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	78	5	2007	2007	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	78	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	78	7	34:118–119	34:118–119	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	78	8	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	79	1	16	16	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	79	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	80	1	Rice	Rice	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	2	KL	KL	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	4	Rubins	Rubins	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	5	JB	JB	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	7	Lebahn	Lebahn	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	8	F	F	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	9	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	10	Parenti	Parenti	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	11	CM	CM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	12	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	13	Duane	Duane	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	14	PG	PG	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	15	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	16	Kuskowski	Kuskowski	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	17	M	M	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	18	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	19	Joseph	Joseph	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	20	AM	AM	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	21	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	80	22	Niewoehner	Niewoehner	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	23	DE	DE	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	24	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	80	25	Withdrawal	withdrawal	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	80	26	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	80	27	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	80	28	systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	80	29	corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	80	30	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	80	31	patients	patient	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	80	32	with	with	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	80	33	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	80	34	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	80	35	a	a	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	80	36	randomized	randomized	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	80	37	trial	trial	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	80	38	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	81	1	Am	Am	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	81	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	81	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	81	4	Crit	Crit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	81	5	Care	Care	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	81	6	Med	Med	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	81	7	2000	2000	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	81	8	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	81	9	162:174–178	162:174–178	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	81	10	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	82	1	17	17	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	82	2	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	83	1	Postma	Postma	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	2	DS	DS	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	3	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	83	4	Steenhuis	Steenhuis	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	5	EJ	EJ	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	83	7	van	van	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	8	der	der	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	83	9	Weele	Weele	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	10	LT	LT	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	11	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	83	12	Sluiter	Sluiter	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	13	HJ	HJ	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	14	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	83	15	Severe	severe	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	83	16	chronic	chronic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	83	17	airflow	airflow	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	83	18	obstruction	obstruction	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	83	19	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	83	20	can	can	MD
work_cmb5a3ntvzalhowblcxqo6o7xy	83	21	corticosteroids	corticosteroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	83	22	slow	slow	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	83	23	down	down	RP
work_cmb5a3ntvzalhowblcxqo6o7xy	83	24	progression	progression	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	83	25	?	?	.
work_cmb5a3ntvzalhowblcxqo6o7xy	84	1	Eur	Eur	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	84	2	J	J	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	84	3	Respir	Respir	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	84	4	Dis	Dis	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	84	5	1985	1985	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	84	6	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	84	7	67:56–64	67:56–64	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	84	8	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	85	1	doi:10.1186/1465	doi:10.1186/1465	FW
work_cmb5a3ntvzalhowblcxqo6o7xy	85	2	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	85	3	9921	9921	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	85	4	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	85	5	15	15	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	85	6	-	-	HYPH
work_cmb5a3ntvzalhowblcxqo6o7xy	85	7	38	38	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	85	8	Cite	Cite	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	85	9	this	this	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	85	10	article	article	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	85	11	as	as	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	85	12	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	85	13	Vogelmeier	vogelmeier	XX
work_cmb5a3ntvzalhowblcxqo6o7xy	85	14	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	85	15	Systemic	systemic	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	85	16	steroids	steroid	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	85	17	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	85	18	COPD	COPD	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	85	19	-	-	:
work_cmb5a3ntvzalhowblcxqo6o7xy	85	20	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	85	21	beauty	beauty	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	85	22	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	85	23	the	the	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	85	24	beast	beast	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	85	25	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	86	1	Respiratory	Respiratory	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	86	2	Research	Research	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	86	3	2014	2014	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	86	4	15:38	15:38	CD
work_cmb5a3ntvzalhowblcxqo6o7xy	86	5	.	.	.
work_cmb5a3ntvzalhowblcxqo6o7xy	87	1	Submit	submit	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	87	2	your	-PRON-	PRP$
work_cmb5a3ntvzalhowblcxqo6o7xy	87	3	next	next	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	4	manuscript	manuscript	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	5	to	to	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	6	BioMed	BioMed	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	7	Central	Central	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	8	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	87	9	take	take	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	87	10	full	full	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	11	advantage	advantage	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	12	of	of	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	13	:	:	:
work_cmb5a3ntvzalhowblcxqo6o7xy	87	14	•	•	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	87	15	Convenient	convenient	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	16	online	online	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	17	submission	submission	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	18	•	•	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	19	Thorough	thorough	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	20	peer	peer	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	21	review	review	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	22	•	•	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	23	No	no	DT
work_cmb5a3ntvzalhowblcxqo6o7xy	87	24	space	space	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	25	constraints	constraint	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	87	26	or	or	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	87	27	color	color	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	28	figure	figure	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	29	charges	charge	NNS
work_cmb5a3ntvzalhowblcxqo6o7xy	87	30	•	•	VBP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	31	Immediate	immediate	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	32	publication	publication	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	33	on	on	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	34	acceptance	acceptance	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	35	•	•	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	36	Inclusion	Inclusion	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	37	in	in	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	38	PubMed	PubMed	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	39	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	87	40	CAS	CAS	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	41	,	,	,
work_cmb5a3ntvzalhowblcxqo6o7xy	87	42	Scopus	Scopus	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	43	and	and	CC
work_cmb5a3ntvzalhowblcxqo6o7xy	87	44	Google	Google	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	45	Scholar	Scholar	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	46	•	•	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	47	Research	Research	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	48	which	which	WDT
work_cmb5a3ntvzalhowblcxqo6o7xy	87	49	is	be	VBZ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	50	freely	freely	RB
work_cmb5a3ntvzalhowblcxqo6o7xy	87	51	available	available	JJ
work_cmb5a3ntvzalhowblcxqo6o7xy	87	52	for	for	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	53	redistribution	redistribution	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	54	Submit	submit	VB
work_cmb5a3ntvzalhowblcxqo6o7xy	87	55	your	-PRON-	PRP$
work_cmb5a3ntvzalhowblcxqo6o7xy	87	56	manuscript	manuscript	NN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	57	at	at	IN
work_cmb5a3ntvzalhowblcxqo6o7xy	87	58	www.biomedcentral.com/submit	www.biomedcentral.com/submit	NNP
work_cmb5a3ntvzalhowblcxqo6o7xy	87	59	References	reference	NNS